Page 66 - JCBP-2-4
P. 66

Journal of Clinical and
            Basic Psychosomatics                                                       Schizophrenia and metabolism



            demonstrating associations with clinical symptoms while   Conflict of interest
            exhibiting a less pronounced correlation with early-stage
            cognitive impairment.  At present, research hotspots   Shen Li is an Editorial Board Member of this journal but
                               40
                                                               was not in any way involved in the editorial and peer-review
            have shifted toward major depressive disorders, mental   process conducted for this paper, directly or indirectly.
            disorders, life cycles, and predictive factors, reflecting   Separately, other authors declared that they have no known
            a transition from mechanistic inquiries to a heightened   competing financial interests or personal relationships that
            emphasis on prevention and treatment strategies. 33
                                                               could have influenced the work reported in this paper.
              This is the first bibliometric analysis delving into the
            realm of research connecting SZ and MS. While this study   Author contributions
            contributes to elucidating prevailing research trends in this   Conceptualization: Shen Li
            interdisciplinary domain, it is crucial to acknowledge its   Formal analysis: Doudou Zheng, Chenghao Lu
            principal limitations. First, while Web of Science stands   Investigation: Simin Yi, Feihong Weng, Nannan Liu
            as a reliable and widely used bibliometric database, its   Methodology: Yanzhe Li, Doudou Zheng
            utilization may inadvertently omit certain research,   Writing–original draft: Simin Yi
            particularly those emanating from non-English language   Writing–review & editing: Shen Li
            sources and drug discovery efforts by pharmaceutical
            companies/biotech. Second, the challenge arises when   Ethics approval and consent to participate
            research institutions undergo name changes over time, a   Not applicable.
            nuance that existing bibliometric analysis methods may
            not fully accommodate.                             Consent for publication
            5. Conclusion                                      Not applicable.
            Scholarly attention to the intricate interplay between   Availability of data
            SZ and MS has burgeoned within academic literature.   Data are available from the corresponding author upon
            The trajectory of this trend is poised to persist over   reasonable request.
            the forthcoming three decades. Despite the surge in
            international cooperation increasing the quantity and   References
            significance of research in this area, the United States   1.   Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet.
            has, so far, spearheaded productivity in this domain.   2022;399:473-486.
            Furthermore, this keyword analysis within this study
            uncovers that MS intersects with SZ but also extends its      doi: 10.1016/s0140-6736(21)01730-x
            influence into the realm of depression patients. Notably,   2.   Valery KM, Prouteau A. Schizophrenia stigma in mental
            the thematic focus has evolved, transitioning from risk   health professionals and associated factors: A  systematic
            factors to considerations  of life  expectancy. Therefore,   review. Psychiatry Res. 2020;290:113068.
            the forthcoming endeavors in this field may increasingly      doi: 10.1016/j.psychres.2020.113068
            pivot toward intervention research centering on MS and   3.   Charlson FJ, Ferrari AJ, Santomauro DF,  et al.  Global
            its relationship with SZ, setting a promising direction for   epidemiology and burden of schizophrenia: Findings from
            future exploration.                                   the global burden of disease study 2016.  Schizophr Bull.
                                                                  2018;44:1195-1203.
            Acknowledgments
                                                                  doi: 10.1093/schbul/sby058
            We thank all those who have contributed to this article.
                                                               4.   Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic syndrome:
            Funding                                               Updates on pathophysiology and management in 2021. Int J
                                                                  Mol Sci. 2022;23:786.
            This work was financially supported by the National      doi: 10.3390/ijms23020786
            Natural Science Foundation of China (82371512),
            Tianjin Key Medical Discipline (Specialty) Construction   5.   Guest PC. Insulin resistance in schizophrenia. Adv Exp Med
                                                                  Biol. 2019;1134:1-16.
            Project  (TJYXZDXK-033A),    Tianjin  Municipal
            Education Commission Scientific Research Program      doi: 10.1007/978-3-030-12668-1_1
            Project (2022KJ265), and Foundation of Tianjin Health   6.   Zhang Y, Wang Q, Reynolds GP, et al. Metabolic effects of
            Commission for Young Scholars (TJWJ2021QN064).        7  antipsychotics  on  patients  with  schizophrenia:  A  short-


            Volume 2 Issue 4 (2024)                         10                              doi: 10.36922/jcbp.4238
   61   62   63   64   65   66   67   68   69   70   71